review Open AccessTop 1% cited

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

Diabetes Care · 2010 · Vol. 33(10) · pp. 2285–2293

Solomon Tesfaye✉(Sheffield Teaching Hospitals NHS Foundation Trust)Andrew J.M. Boulton(University of Manchester)Peter James Dyck(Mayo Clinic)Roy Freeman(Harvard University)Michael Horowitz(University of Adelaide)Péter Kempler(Semmelweis University)Giuseppe Lauria(Fondazione IRCCS Istituto Neurologico Carlo Besta)Rayaz A. Malik(University of Manchester)Vincenza Spallone(University of Rome Tor Vergata)Aaron I. Vinik(Eastern Virginia Medical School)Luciano Bernardi(University of Pavia)Paul Valension behalf of the Toronto Diabetic Neuropathy Expert Group

View via DOI Full-text PDF

Abstract

Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13-18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.

Pain Mechanisms and Treatments Heart Rate Variability and Autonomic Control Botulinum Toxin and Related Neurological DisordersMedicineDiabetes mellitusPeripheral neuropathyDiabetic neuropathyMEDLINEIntensive care medicinePhysical therapyFamily medicineEndocrinology